Search

Search Results

• Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical Institutions

  Vladislav Vitalevich Markelov, Iu.S. Osipov, Yu.A. Alekseeva, S.V. Voloshin, N.A. Khasanova, S.A. Volchenkov, E.A. Ukrainchenko, E.S. Pavlyuchenko, A.Yu. Kuvshinov, Ju.N. Vinogradova, A.N. Gavrilenko, O.S. Uspenskaya, M.A. Ulyanova, V.G. Potapenko, I.A. Samorodova, V.V. Ryabchikova, I.S. Zyuzgin, A.M. Chekalov, M.V. Krivitskaya, Ya.B. Skiba, M.O. Popova, E.V. Kondakova, L.V. Stelmakh, L.V. Fedorova, K.V. Lepik, A.A. Gusak, V.V. Baykov, N.V. Medvedeva, G.N. Salogub, N.B. Mikhailova, A.D. Kulagin

  253-263

  01.07.2026

• Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

  E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova

  142-151

  01.04.2026

• Pregnancy Management in Patients with Ph-Negative Myeloproliferative Neoplasms: A Literature Review and Case Report

  Kristina Teimurazovna Poghosyan, A.L. Melikyan, E.A. Gilyazitdinova, I.N. Subortseva, Z.V. Tratsevskaya, E.S. Polushkina, E.E. Sudneva, E.A. Kitsenko

  220-228

  01.04.2026

• Efficacy and Tolerability of the PET-Guided Program BrECADD for Advanced Stages of Classical Hodgkin Lymphoma: Data from the Real-World Setting in Russia

  Elena Andreevna Demina, O.S. Samoilova, A.V. Halturin, O.M. Malchuk, V.O. Sarzhevskiy, A.A. Samoylova, G.S. Tumyan, A.A. Semenova, A.F. Saidullaeva, K.D. Kaplanov, N.E. Mochkin, N.S. Shorokhov, Yu.V. Protopopova, V.Ya. Melnichenko

  172-179

  01.04.2026

• The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

  Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev

  39-48

  01.01.2026

• Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

  Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin

  49-58

  01.01.2026

• Quality of Life and Symptom Profile in Polycythemia Vera Patients on Ruxolitinib Therapy in a Real-World Setting: Results of a Multi-Center Prospective Observational Study

  T.I. Ionova, Tatyana Pavlovna Nikitina, A.V. Proidakov, E.V. Lyurova, E.M. Volodicheva, L.A. Mkhitaryan, Yu.P. Martinova, T.V. Chitanava, N.B. Esefeva, M.O. Ivanova, T.I. Pospelova, A.S. Lyamkina, E.A. Knyazeva, E.G. Lomaia, N.S. Lazorko, K.P. Novoselov, D.A. Lipatova, N.M. Porfirieva, A.D. Kulagin

  14-26

  01.01.2026

• Gene Methylation Profile in Hematologic Malignancies

  Mariia Andreevna Mikhaleva, A.A. Zherniakova, O.B. Krysiuk, S.V. Sidorkevich

  27-38

  01.01.2026

• Fertility Preservation Strategies in Patients with Lymphoproliferative Diseases

  A.M. Biryukova, Ya.O. Martirosyan, Valeria Olegovna Shpirko, T.A. Nazarenko, G.S. Tumyan

  90-95

  01.01.2026

• Treatment Opportunities in Epstein-Barr Virus-Associated Chronic Active Disease and Secondary Hemophagocytic Syndrome: A Case Series

  Vsevolod Gennadevich Potapenko, M.M. Antonov, D.D. Avdoshina, M.M. Aksenova, V.V. Baykov, M.B. Belogurova, I.A. Bekhtereva, L.V. Glyzhina, E.N. Dulaeva, Yu.V. Zabutova, V.E. Karev, N.A. Kotova, V.V. Kozyro, Yu.A. Krivolapov, T.G. Kulibaba, S.V. Lapin, E.E. Leenman, N.B. Mikhailova, S.I. Moiseev, A.A. Molchan, M.Yu. Pervakova, M.S. Petrova, O.P. Petrova, N.A. Potikhonova, V.V. Ryabchikova, D.R. Rakhimzyanova, I.A. Samorodova, A.V. Serkov, I.A. Skorokhod, K.V. Skoriukova, N.V. Skorobogatova, I.M. Slashcheva, E.A. Surkova, D.R. Smirnov, M.N. Smirnova, O.P. Mironova, O.V. Nebelitskaia, Yu.A. Nesterov, I.P. Fedunyak, A.N. Kholodnaia, N.Yu. Chernookaya, D.A. Chaginskaya, N.V. Medvedeva

  355-371

  01.10.2025

• Comparative Assessment of Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors Registered in the Russian and International Databases for Hematologic Diseases

  Anastasiya Viktorovna Beynarovich, A.L. Alyanskii, K.S. Afanaseva, L.V. Fedorova, A.M. Chekalov, E.A. Bakin, N.E. Ivanova, A.A. Golovacheva, E.V. Babenko, M.A. Estrina, O.G. Smykova, Yu.Yu. Vlasova, E.V. Morozova, N.B. Mikhailova, A.G. Smirnova, S.N. Bondarenko, M.D. Vladovskaya, D.E. Pevtsov, A.A. Vitrishchak, I.S. Moiseev, A.D. Kulagin, L.S. Zubarovskaya, B.V. Afanasyev

  257-269

  01.07.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• Which Calculations Are Required for Treating Patients with Multiple Myeloma?

  Aleksander Sergeevich Luchinin, A.A. Semenova

  218-226

  01.07.2025

• Comparative Efficacy Analysis of Mobilization and Collection of Autologous Hematopoietic Stem Cells in Patients with Lymphoproliferative Disorders and Multiple Sclerosis

  Oksana Vladimirovna Fedyk, V.O. Sarzhevskii, D.A. Fedorenko, V.Ya. Mel’nichenko, Yu.N. Dubinina, N.E. Mochkin, E.G. Smirnova, D.S. Kolesnikova, A.E. Bannikova

  51-58

  01.07.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Personalized Approach to Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients with Respect to Molecular Landscape: A Case Report and Literature Review

  Marat Albertovich Mingalimov, E.A. Baryakh, T.N. Tolstykh, A.V. Misyurin, L.A. Kesaeva, A.S. Mkrtchyan, A.M. Kovrigina, E.N. Misyurina, M.S. Orlova, T.S. Chudnova, D.D. Ivanova, O.L. Kochneva, S.S. Andreev, K.V. Yatskov, I.V. Samsonova, M.A. Lysenko

  177-183

  01.04.2025

• Esophagogastric Bleedings in Patients with Ph-Negative Myeloproliferative Neoplasms and Extrahepatic Portal Hypertension

  Pavel Artemovich Batrov, K.I. Danishian, E.P. Sysoeva, K.R. Sabirov, O.M. Averbukh, O.A. Soboleva, E.A. Kitsenko, E.A. Lukina

  163-170

  01.04.2025

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure

  Ekaterina Alekseevna Karimova, E.I. Zhelnova, E.A. Baryakh, E.Yu. Grishina, E.N. Zotina, D.E. Gagloeva, V.N. Yakimets, O.L. Kochneva, E.N. Misyurina

  171-176

  01.04.2025

• Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

  Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin

  153-162

  01.04.2025

• Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials

  Margarita Andreevna Ulyanova, V.I. Vorobyev, L.A. Bychenkova, S.V. Semochkin

  145-152

  01.04.2025

• Treatment Outcomes in Primary Mediastinal Large B-Cell Lymphoma. Experience of the AF Tsyb Medical Radiological Research Center (Obninsk)

  Alena Yurevna Terekhova, N.A. Falaleeva, A.B. Galitsyna, A.M. Chelmakov, A.A. Vovchenko, N.A. Riabikina, A.A. Danilenko, T. I. Bogatyreva

  225-236

  01.07.2024

• KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

  Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva

  256-265

  01.07.2024

• Impact of Cardiac Disease on Prognosis in Patients with Systemic AL Amyloidosis

  Olga Vladislavovna Pirogova, O.V. Kudyasheva, M.V. Chernous, M.A. Gorodnova, D.K. Lamden, K.A. Novitskaya, A.G. Smirnova, A.V. Yakovleva, V.A. Ionin, A.M. Ananin, I.S. Moiseev, A.D. Kulagin

  237-245

  01.07.2024

• Treatment of Patients with Local Stages of Newly Diagnosed Classical Hodgkin Lymphoma: A Literature Review, Current Approaches, and Our Own Experience

  Evgeniya Viktorovna Paramonova, Yu.I. Klyuchagina, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.V. Arakelyan, A.A. Semenova, E.A. Demina, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, G.S. Tumyan

  27-36

  17.05.2024

• Nivo-DHAP Combined with Subsequent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Trial (ClinicalTrials.gov, NCT04091490)

  V.O. Sarzhevskii, Aisel Akifovna Mamedova, N.E. Mochkin, E.A. Demina, A.A. Spornik, A.A. Samoilova, V.S. Bogatyrev, A.A. Rukavitsyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko, N.B. Mikhailova, E.S. Borzenkova, L.V. Stelmakh, Yu.R. Zalyalov, A.A. Semenova, G.S. Tumyan, M.A. Danilova, O.A. Konova, N.A. Falaleeva, AYu Terekhova, M.A. Vernyuk, A.M. Chervontseva, L.S. Khairullina, A.A. Maslov, I.B. Lysenko, Yu.A. Alekseeva, E.S. Pavlyuchenko, A.A. Mirsaitov, A.A. Zverkova, I.V. Ishmatova, S.A. Volchenkov, M.S. Motalkina, I.S. Zyuzgin

  1-10

  17.05.2024

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• BAALC-Expressing Leukemia Hematopoietic Stem Cells and Their Place in the Study of CBF-Positive Acute Myeloid Leukemias in Children and Adults

  M.M. Kanunnikov, Nikolai Nikolaevich Mamaev, T.L. Gindina, A.I. Shakirova, A.M. Sadykov, S.V. Razumova, S.N. Bondarenko, L.S. Zubarovskaya

  387-398

  28.09.2023

• Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

  Anna Anatolevna Spornik, N.S. Vasilev, A.A. Samoilova, A.A. Mamedova, V.S. Bogatyrev, E.G. Smirnova, A.A. Bannikova, A.A. Rukavitsyn, N.S. Shorokhov, N.E. Mochkin, V.O. Sarzhevskii, E.A. Demina, V.Ya. Melnichenko

  370-379

  28.09.2023

• An Optimal Multi-Locus HLA-Typing in Potential Donors of Allogeneic Hematopoietic Stem Cells

  Ekaterina Georgievna Khamaganova, S.P. Khizhinskii, E.P. Kuzminova, A.R. Abdrakhimova, E.A. Leonov, T.V. Gaponova, E.N. Parovichnikova

  399-406

  28.09.2023

• Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience

  Elena Romanovna Shilova, N.A. Romanenko, D.A. Chebykina, T.V. Glazanova, M.N. Zenina, I.E. Pavlova, S.S. Bessmeltsev

  321-330

  09.06.2023

• Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy

  A.G. Turkina, Elena Andreevna Kuzmina

  311-320

  09.06.2023

• Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment

  Artem Aleksandrovich Gusak, K.V. Lepik, L.V. Fedorova, V.V. Markelov, V.V. Baykov

  242-262

  09.06.2023

• The Role of Autologous Hematopoietic Stem Cell Transplantation in the Therapy of Systemic AL Amyloidosis

  Olga Vladislavovna Pirogova, O.V. Kudyasheva, A.G. Smirnova, V.V. Porunova, S.V. Tolstova, K.R. Kalimulina, M.V. Chernous, Yu.Yu. Vlasova, I.S. Moiseev, V.A. Dobronravov, A.D. Kulagin

  128-136

  03.03.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• Long-Term Results of Classical Hodgkin’s Lymphoma Treatment in Real-World Clinical Practice: Experience of Novosibirsk Hematological Unit

  Mariya Sergeevna Voitko, T.I. Pospelova, I.N. Nechunaeva, Ya.Yu. Shebunyaeva

  192-199

  03.03.2023

• Efficacy of Combined Drug Pre-transplant Conditioning Regimens in Multiple Myeloma Patients with Single Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.S. Zhuk, Zh.Yu. Sidorova, R.R. Sabitova, A.Yu. Aksenova, O.B. Belopolskaya, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  88-95

  01.01.2023

• Prognostic Models in Medicine

  Aleksander Sergeevich Luchinin

  27-36

  01.01.2023

• Characteristic Features of the Novel Coronavirus Infection COVID-19 in Oncohematological Patients

  Nikolai Aleksandrovich Romanenko, E.R. Shilova, L.V. Stelmashenko, E.I. Kaitandzhan, A.V. Kuleshova, N.P. Stizhak, V.N. Chebotkevich, S.V. Sidorkevich, S.V. Gritsaev, S.S. Bessmeltsev

  101-108

  01.01.2023

• Acute Myeloid Leukemias After the Treatment of Classical Hodgkin’s Lymphoma: A Literature Review

  Anatolii Aleksandrovich Danilenko, S.V. Shakhtarina, N.A. Falaleeva

  414-423

  01.10.2022

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022